CORRESP Filing
ALUMIS INC.
Date: April 22, 2025 · CIK: 0001847367 · Accession: 0001104659-25-037513
AI Filing Summary & Sentiment
File numbers found in text: 333-286660
Show Raw Text
CORRESP 1 filename1.htm Alumis Inc. 280 East Grand Avenue South San Francisco, California 94080 April 22, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, N.E. Washington, D.C. 20549 Re: Alumis Inc. Registration Statement on Form S-4 (File No. 333-286660) Request for Acceleration of Effective Date Ladies and Gentlemen: This letter is sent on behalf of Alumis Inc. (the " Company ") in connection with the above-referenced Registration Statement on Form S-4 (the " Registration Statement ") filed with the Securities and Exchange Commission (the " Commission ") by the Company pursuant to the Securities Act of 1933, as amended (the " Securities Act "). Pursuant to Rule 461 promulgated under the Securities Act, the Company hereby requests that the effective date of the Registration Statement be accelerated to 4:00 p.m., Eastern Time, on April 23, 2025, or as soon thereafter as practicable, or at such other time as its legal counsel, Cooley LLP, may request by telephone to the staff of the Commission. The Company hereby authorizes Kristin VanderPas and David Peinsipp of Cooley LLP, counsel to the Company, to orally modify or withdraw this request for acceleration. Once the Registration Statement has been declared effective, please orally confirm that event with Kristin VanderPas of Cooley LLP at (415) 693-2097 or, in her absence, David Peinsipp of Cooley LLP at (415) 693-2177. Very truly yours, Alumis Inc. /s/ Martin Babler By: Martin Babler Title: Chief Executive Officer cc: Sara Klein, Chief Legal Officer, Alumis Inc. Jamie Leigh, Cooley LLP Ben Beerle, Cooley LLP Kristin VanderPas, Cooley LLP David Peinsipp, Cooley LLP Stefano Quintini, Fenwick & West LLP Ethan Skerry, Fenwick & West LLP Ryan Mitteness, Fenwick & West LLP Jeremy Delman, Fenwick & West LLP Mina Kim, Chief Executive Officer, ACELYRIN, Inc.